BIT
NVIV

BlackRock Institutional Trust’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

BlackRock Institutional Trust’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.35M Buy
43
+2
+5% +$179K ﹤0.01% 2870
2016
Q3 		$5.23M Hold
41
– – ﹤0.01% 2673
2016
Q2 		$4.43M Buy
41
+2
+5% +$235K ﹤0.01% 2735
2016
Q1 		$5.12M Buy
39
+4
+11% +$429K ﹤0.01% 2656
2015
Q4 		$4.77M Buy
35
+5
+17% +$743K ﹤0.01% 2758
2015
Q3 		$4.84M Buy
30
+13
+76% +$3.04M ﹤0.01% 2739
2015
Q2 		$5.08M Buy
+17
New +$4.49M ﹤0.01% 2765

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Institutional Trust's NVIV Position: Q4 2016 in Review

BlackRock Institutional Trust increased its InVivo Therapeutics Holdings Corp (NVIV) stake by 4.9% in Q4 2016, buying an estimated $179K and bringing the position to 43 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2870.

BlackRock Institutional Trust first reported a position in NVIV in Q2 2015 and has held it in 7 quarters since. The position peaked at $5.23M in Q3 2016. 51 funds tracked by Wall St. Rank hold NVIV as of Q4 2016.

  • BlackRock Institutional Trust held 43 shares of InVivo Therapeutics Holdings Corp worth $3.35M as of Q4 2016.
  • BlackRock Institutional Trust bought 2 InVivo Therapeutics Holdings Corp shares in Q4 2016, an estimated $179K.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2870 holding.
  • BlackRock Institutional Trust first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Institutional Trust's InVivo Therapeutics Holdings Corp position peaked at $5.23M in Q3 2016.
  • 51 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.